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A B S T R A C T
Visceral leishmaniasis due to Leishmania infantum is a vector-borne zoonotic disease transmitted by sand
ﬂy bites endemic in rural or periurban areas of the Mediterranean basin. Pregnancy is accompanied by
changes in immune response, mainly a decrease in cellular immunity and a proportional increase in
humoral immunity. These physiological events result in increased risk of infection by pathogens whose
immunity is based on a T-helper 1 predominant response. We describe a case of visceral leishmaniasis
and pulmonary tuberculosis diagnosed in a post-partum woman four days after delivery. The diagnosis
of leishmaniasis should be considered in pregnant women with fever and haematologic abnormalities in
endemic regions or if a history of exposure in endemic areas is reported.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Background
Visceral leishmaniasis (VL) due to Leishmania infantum is a
vector-borne zoonotic disease transmitted by sand ﬂy bites
endemic in rural or periurban areas of the Mediterranean basin.
An estimated 47% of the population in Sicily, the largest island in
the Mediterranean Sea, lives in areas at risk for Leishmania
infection. In the Mediterranean the incidence of leishmaniosis is
estimated to be at least 1000 cases per year, and dogs provide the
reservoir for Leishmania infantum. The disease disproportionately
affects children and immunodepressed patients, more frequently
involved because of a relative inability to contain the infection.1
Few case reports of VL in pregnancy have been reported in the
literature.2 Co-infection of visceral leishmaniasis and tuberculosis
is an important public problem; both diseases appear to be riskAbbreviations: VL, Visceral leishmaniasis; BCG, Bacillus Calmette–Gue´rin; PCR,
Polymerase chain reaction; IGRA, Interferon Gamma Release Assays; TB,
tuberculosis.
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).factors for each other. We describe a case of VL and pulmonary
tuberculosis diagnosed in a post-partum woman.
2. Case presentation
In January 2014, a previously healthy Romanian female aged
22 years, recently immigrated from Eastern Europe, was admitted
to the Infectious Diseases Unit of the University Hospital of
Palermo, Italy, due to fever, headache and sweats. The symptoms
had begun six days before, a few hours after delivery.
On admission, the patient was febrile (body temperature
37.7 8C); blood pressure 110/70 mm Hg, oxygen saturation of 97%.
The complete blood count demonstrated a white blood cell count
of 2850 cells/mm3, haemoglobin 11.8 g/dL, platelets 84000-
111000 cells/mm3; erythrocyte sedimentation rate 48 mm/h,
C-reactive protein 9.12 mg/dL and a very slight increase of gamma
globulins (19.3% at the serum protein electrophoresis, range value
10,5- 18,8). Physical examination demonstrated hepatosplenome-
galy, conﬁrmed by ultrasound (spleen size approximately 20 cm).
A chest X-ray demonstrated radiopaque rounded areolas in the
right superior-middle and left middle lung ﬁelds.
Blood cultures were performed and resulted negative; empiric
anti-microbial therapy with meropenem, amikacin and clindamy-
cin was initiated without improvement. Persistent fever, progres-
sive anemia, splenomegaly and a history of a ﬁrst daughterciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
C. Colomba et al. / International Journal of Infectious Diseases 33 (2015) 5–66recently treated for leishmaniasis led us to perform speciﬁc testing
for antileishmanial antibodies. Immunoﬂuorescent antibody-test
(IFAT) test was positive 1:3200; ELISA IgG positive. Quantitative
polymerase chain reaction (PCR) assay on blood and on bone
marrow aspirate for detection of leishmania-DNA were both
positive (1200 n.leish/ml on blood; 5500 n.leish/ml on bone
marrow aspirate). Light-microscopic examination of the stained
bone marrow specimen was positive for Leishmania amastigotes.
Therapy was initiated with liposomal amphotericin B (l-AmB)
at the dosage of 3 mg/kg at days 1–5 and at day 10. The patient
defervesced and clinically improved.
Because of a positive (20 mm) tuberculin skin test (TST), an
Interferon-Gamma Release Assay (1,04 IU/ml) (QuantiFERON-TB
Gold, Cellestis, Ltd., Carnegie, Australia) was performed and
conﬁrmed immune reactivity to Mycobacterium tuberculosis (Mtb).
A computed tomography of the chest demonstrated the
presence of numerous nodules in the right upper lobe, images
of micronodulia as ‘‘tree-in-bud’’, and interstitial thickening in the
right middle lobe and in the left apical-dorsal segments. These
ﬁndings were suspicious for pulmonary TB, so bronchoscopy was
performed. A bronchoalveolar lavage specimen was positive for
Mtb PCR, and cultures grew Mtb which was susceptible to
rifampin, isoniazid, pyrazinamide, and ethambutol. She was
started on standard 4-drug TB therapy. The newborn was
investigated for Leishmaniasis, the serological test was positive
and consistent with the result obtained from the mother, but PCR
for leishmania-DNA on peripheral blood resulted negative. The
infant also was evaluated for tuberculosis with TST test and chest
radiography, according to CDC guidelines, and resulted negative.
3. Discussion
Normal pregnancy is accompanied by changes in immune
response, mainly a decrease in cellular immunity and a propor-
tional increase in humoral immunity, which may in part account
for the successful growth and delivery of the fetus hemi-allograft.
These physiological events result in an increase in the risk for
infections sustained by some infectious agents whose immunity is
based on a T-helper 1 predominant response. Although on the basis
of this immunological evidence the risk of VL during pregnancy
may be higher, no speciﬁc epidemiological data support the
hypothesis. These changes in immune response may potentially
have some effects on Mycobacterium tuberculosis infection too,
even if literature indicates that pregnancy does not affect the
course of tuberculosis.
Clinical ﬁndings of VL in immunocompetent hosts varies from
asymptomatic to severe forms, even fatal if not treated. Various
factors have been associated with the development of symptom-
atic VL, including age less than ﬁve years, malnutrition, decreased
lymphocyte proliferation, low production of interferon gamma,
HIV infection and pregnancy.3 Asymptomatic infection is the most
common clinical form of Leishmania infection in endemic areas.3,4
Family members and neighbors of patients with a history of classic
VL are more susceptible to acquiring the disease due to similar
exposures.5
In our report, the patient was young and she had no underlying
diseases; her risk factors consisted of living in a rural area, and a
daughter with a recent diagnosis of Leishmaniasis. She showed the
typical clinical features of the disease, with fever, hepatospleno-
megaly and pancytopenia. A careful evaluation of the diagnosis of
leishmaniasis in pregnant women with fever and haematological
abnormalities is necessary in an endemic area or if a history ofexposure in endemic areas is reported. Therapy with l-AmB
conﬁrmed its efﬁcacy.6
With respect to tuberculosis, Italy is considered a country with
low prevalence, but the increasing immigration from countries
with a high risk level (i.e. East Europe) suggests a need for
increased awareness of the problem.
The diagnosis of tuberculosis in pregnancy or during puerperi-
um may be more difﬁcult, as certain symptoms (e.g., increased
respiratory rate, malaise, fatigue) may initially be ascribed to the
pregnancy.
In our report, the patient had no respiratory symptoms and
presented with only fever and malaise. Only the positive result of
TST and IGRA screening tests led to additional evaluation and
treatment for TB.
Considering the very limited number of cases reported in the
literature, VL in pregnancy should be considered to be a rare
occurrence. However, the present report demonstrates that the
risk of VL during pregnancy has to be considered in endemic areas.
The patient we described lived in and possibly contracted the
infection in a rural area of Sicily where she recently immigrated
from Eastern Europe. Adults moving from non-endemic to endemic
countries could be at higher risk of contracting VL due to lack of
previous immunity. However, VL in pregnant women also should
be considered among urban and peri-urban residents who are less
likely to have been exposed to Leishmania during childhood.
Therefore, a careful evaluation of the diagnosis of leishmaniasis in
pregnant women with fever and haematological abnormalities
would be necessary in an endemic area or if a history of recent
exposure in endemic areas is reported. Early diagnosis of VL in
pregnancy also would be needed to rule out the risk of congenital
infection and establish appropriate treatment. TB is generally
acknowledged to complicate VL since both clinical syndromes are
inﬂuenced by the quality of the cell mediated immune response
and the prognosis for progression to active disease of co-infected
individuals is likely to be different from those with a single
infection.
As demonstrated by the present report, LTBI screening would be
advisable in VL patients in order to detect co-infection.
Acknowledgements
We have not received substantial contributions from non-
authors.
Competing interests: The authors declare that they have no
competing interests.
References
1. Cascio A, Colomba C, Antinori S, Orobello M, Paterson D, Titone L. Pediatric
visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of
111 cases. Eur J Clin Microbiol Infect Dis 2002 Apr;21(4):277–82.
2. Pagliano P, Carannante N, Rossi M, Gramiccia M, Gradoni L, Faella FS, et al.
Visceral leishmaniasis in pregnancy: a case series and a systematic review of the
literature. J Antimicrob Chemother 2005 Feb;55(2):229–33.
3. Saporito L, Giammanco GM, De Grazia S, Colomba C. Visceral leishmaniasis:
host-parasite interactions and clinical presentation in the immunocompe-
tent and in the immunocompromised host. Int J Infect Dis 2013 Aug;17(8):
e572–6.
4. Colomba C, Saporito L, Polara VF, Barone T, Corrao A, Titone L. Serological
screening for Leishmania infantum in asymptomatic blood donors living in an
endemic area (Sicily, Italy). Transfus Apher Sci 2005 Nov;33(3):311–4.
5. Moura GS, Santos AM, Aquino DM, Silva AA, Caldas Ade J. Factors associated with
asymptomatic infection in family members and neighbors of patients with
visceral leishmaniasis. Cad Saude Publica 2012 Dec;28(12):2306–14.
6. Di Masi F, Ursini T, Iannece MD, Chianura L, Baldasso F, Foti G, et al. Five-year
retrospective Italian multicenter study of visceral leishmaniasis treatment.
Antimicrob Agents Chemother 2014;58(1):414–8.
